GE HealthCare
GEHC
Market cap $37.4B

81.76 USD

-1.16

1.40%

At close Nov 15, 4:00 PM EST

After hours

81.98

+0.22

0.27%

1 day

-1.40%

5 days

-6.02%

1 month

-9.87%

3 months

-4.15%

6 months

-0.18%

Year to date

7.06%

1 year

14.32%

5 years

36.27%

10 years

36.27%

About: GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

Employees: 51,000

Healthcare X-Ray Apparatus & Tubes & Related Irradiation Apparatus

0

Funds holding %

of 6,704 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

25% more funds holding in top 10

Funds holding in top 10: 8 [Q2] → 10 (+2) [Q3]

24% more first-time investments, than exits

New positions opened: 155 | Existing positions closed: 125

19% more capital invested

Capital invested by funds: $29.5B [Q2] → $35B (+$5.53B) [Q3]

15% more repeat investments, than reductions

Existing positions increased: 453 | Existing positions reduced: 393

12% more call options, than puts

Call options by funds: $579M | Put options by funds: $518M

3% more funds holding

Funds holding: 1,191 [Q2] → 1,221 (+30) [Q3]

0.99% less ownership

Funds ownership: 82.85% [Q2] → 81.86% (-0.99%) [Q3]

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$74

9%

downside

Avg. target

$94

15%

upside

High target

$102

25%

upside

6 analyst ratings

4 positive

67%

1 neutral

17%

1 negative

17%

Wells Fargo Larry Biegelsen 60% 1-year accuracy 25 / 42 met price target	17%upside $96	Overweight Maintained	31 Oct 2024
Evercore ISI Group Vijay Kumar 65% 1-year accuracy 30 / 46 met price target	25%upside $102	Outperform Maintained	1 Oct 2024
Stifel Rick Wise 74% 1-year accuracy 20 / 27 met price target	25%upside $102	Buy Maintained	30 Sept 2024
UBS Graham Doyle 50% 1-year accuracy 1 / 2 met price target	9%downside $74	Sell Downgraded	26 Sept 2024
BTIG Ryan Zimmerman 66% 1-year accuracy 29 / 44 met price target	22%upside $100	Buy Upgraded	18 Sept 2024

See Analyst Rankings

Financial journalist opinion

Based on 29 articles about GEHC published over the past 30 days

Zacks Investment Research

GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging

GEHC and DeepHealth collaborate to develop AI-based imaging tools that can streamline workflow and help manage large imaging volumes without compromising diagnostic accuracy.

GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging

Zacks Investment Research

GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System

GE Healthcare receives FDA clearance for its head-only SIGNA MAGNUS 3.0T MRI System.

GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System

GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions. The FDA clearance of SIGNA MAGNUS underscores the advances made by GE HealthCare in neuroimaging. It features an innov.

GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an initiative with AMN Healthcare aimed at helping address the critical shortage of radiologic technologists (rad tech) in the healthcare industry. This initiative helps healthcare providers meet their immediate staffing needs through AMN Healthcare's comprehensive workforce solutions and GE HealthCare's innovative technologies and training expertise. Several factors contributing to the current shortage of rad techs include.

GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

Schaeffers Research

RadNet Stock Pops on Earnings, GE HealthCare Partnership

Radnet Inc (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter.

RadNet Stock Pops on Earnings, GE HealthCare Partnership

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping i.

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares

CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closin.

GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares

GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares

CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closing of the Offering, GE Ae.

GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares

GE HealthCare to Host its 2024 Investor Day on November 21

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will host its Investor Day on Thursday, November 21, 2024, at Nasdaq MarketSite in New York, NY, where its management team will present its growth strategies, technology portfolio, and vision for its businesses. A technology showcase will follow the presentations for in-person attendees. Registration is required. The live webcast will be available at https://investor.gehealthcare.com/news-events/events.The press release, presentation, and w.

GE HealthCare to Host its 2024 Investor Day on November 21

Zacks Investment Research

Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock

See News Rankings

Charts implemented using Lightweight Charts™